(Q73653658)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Early appearance of neutralizing antibodies after vaccination with an inactivated hepatitis A vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

1 reference

B Flehmig

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

H Staedele

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

C Xueref

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

E Vidor

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

J Zuckerman

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

A Zuckerman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 July 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

37-40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

Neutralizing antibody to hepatitis A virus in immune serum globulin and in the sera of human recipients of immune serum globulin

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Efficacy of different doses of immune serum globulin in the prevention of hepatitis A: a three-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Serum Neutralizing Antibody Response to Hepatitis A Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

A Simple Antigen-Reduction Assay for the Measurement of Neutralizing Antibodies to Hepatitis A Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Levels of Neutralizing and Binding Antibodies to Hepatitis-A Virus after Onset of Icterus: A Comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Genetic, antigenic and biological differences between strains of hepatitis A virus

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Safety profile and immunogenicity of an inactivated vaccine derived from an attenuated strain of hepatitis A.

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Safety and immunogenicity of an inactivated hepatitis A candidate vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Characterization of the immune response of volunteers vaccinated with a killed vaccine against hepatitis A

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Laboratory tests and reference reagents employed in studies of inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Properties of a hepatitis A virus candidate vaccine strain

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Production, quality control and characterization of an inactivated hepatitis A vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Immunogenicity and safety of a new inactivated hepatitis A vaccine in a comparative study

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Sensitive assays for hepatitis A antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

Protection against hepatitis A by an inactivated vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0163-4453%2897%2990929-4

7 January 2021

10.1016/S0163-4453(97)90929-4

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9279722%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference